BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17298049)

  • 1. N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1-methylprop-2-ynyl}carboxy derivatives as acetyl-coA carboxylase inhibitors--improvement of cardiovascular and neurological liabilities via structural modifications.
    Gu YG; Weitzberg M; Clark RF; Xu X; Li Q; Lubbers NL; Yang Y; Beno DW; Widomski DL; Zhang T; Hansen TM; Keyes RF; Waring JF; Carroll SL; Wang X; Wang R; Healan-Greenberg CH; Blomme EA; Beutel BA; Sham HL; Camp HS
    J Med Chem; 2007 Mar; 50(5):1078-82. PubMed ID: 17298049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy derivatives as selective acetyl-CoA carboxylase 2 inhibitors.
    Gu YG; Weitzberg M; Clark RF; Xu X; Li Q; Zhang T; Hansen TM; Liu G; Xin Z; Wang X; Wang R; McNally T; Zinker BA; Frevert EU; Camp HS; Beutel BA; Sham HL
    J Med Chem; 2006 Jun; 49(13):3770-3. PubMed ID: 16789734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis in rats treated with experimental acetyl-coenzyme A carboxylase inhibitors suggests interactions with the peroxisome proliferator-activated receptor alpha pathway.
    Waring JF; Yang Y; Healan-Greenberg CH; Adler AL; Dickinson R; McNally T; Wang X; Weitzberg M; Xu X; Lisowski A; Warder SE; Gu YG; Zinker BA; Blomme EA; Camp HS
    J Pharmacol Exp Ther; 2008 Feb; 324(2):507-16. PubMed ID: 18025247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, and characterization of human acetyl-CoA carboxylase 2.
    Kim KW; Yamane H; Zondlo J; Busby J; Wang M
    Protein Expr Purif; 2007 May; 53(1):16-23. PubMed ID: 17223360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis and structure-activity relationship studies of selective acetyl-CoA carboxylase inhibitors containing 4-(thiazol-5-yl)but-3-yn-2-amino motif: polar region modifications.
    Xu X; Weitzberg M; Keyes RF; Li Q; Wang R; Wang X; Zhang X; Frevert EU; Camp HS; Beutel BA; Sham HL; Gu YG
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1803-7. PubMed ID: 17234407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships for a novel series of thiazolyl phenyl ether derivatives exhibiting potent and selective acetyl-CoA carboxylase 2 inhibitory activity.
    Clark RF; Zhang T; Xin Z; Liu G; Wang Y; Hansen TM; Wang X; Wang R; Zhang X; Frevert EU; Camp HS; Beutel BA; Sham HL; Gu YG
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6078-81. PubMed ID: 16973360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenoxy thiazole derivatives as potent and selective acetyl-CoA carboxylase 2 inhibitors: Modulation of isozyme selectivity by incorporation of phenyl ring substituents.
    Clark RF; Zhang T; Wang X; Wang R; Zhang X; Camp HS; Beutel BA; Sham HL; Gu YG
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1961-5. PubMed ID: 17267221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide.
    Uto Y; Ogata T; Harada J; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Deguchi T; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Abe M; Kurikawa N; Kawamura S; Yamato M; Osumi J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4151-8. PubMed ID: 19540759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors.
    Kamata M; Yamashita T; Kina A; Tawada M; Endo S; Mizukami A; Sasaki M; Tani A; Nakano Y; Watanabe Y; Furuyama N; Funami M; Amano N; Fukatsu K
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4769-72. PubMed ID: 22677317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and structure-activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors.
    Kamata M; Yamashita T; Kina A; Funata M; Mizukami A; Sasaki M; Tani A; Funami M; Amano N; Fukatsu K
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3643-7. PubMed ID: 22560583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation.
    Uto Y; Ogata T; Kiyotsuka Y; Miyazawa Y; Ueno Y; Kurata H; Deguchi T; Yamada M; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Konishi M; Kurikawa N; Kono K; Osumi J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4159-66. PubMed ID: 19541482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desazadesmethyldesferrithiocin analogues as orally effective iron chelators.
    Bergeron RJ; Wiegand J; Weimar WR; Vinson JR; Bussenius J; Yao GW; McManis JS
    J Med Chem; 1999 Jan; 42(1):95-108. PubMed ID: 9888836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes.
    Cheng D; Chu CH; Chen L; Feder JN; Mintier GA; Wu Y; Cook JW; Harpel MR; Locke GA; An Y; Tamura JK
    Protein Expr Purif; 2007 Jan; 51(1):11-21. PubMed ID: 16854592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: discovery of PSN-GK1.
    Bertram LS; Black D; Briner PH; Chatfield R; Cooke A; Fyfe MC; Murray PJ; Naud F; Nawano M; Procter MJ; Rakipovski G; Rasamison CM; Reynet C; Schofield KL; Shah VK; Spindler F; Taylor A; Turton R; Williams GM; Wong-Kai-In P; Yasuda K
    J Med Chem; 2008 Jul; 51(14):4340-5. PubMed ID: 18588279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.
    Corbett JW
    Expert Opin Ther Pat; 2009 Jul; 19(7):943-56. PubMed ID: 19552511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel olefin derivative as a highly potent and selective acetyl-CoA carboxylase 2 inhibitor with in vivo efficacy.
    Nishiura Y; Matsumura A; Kobayashi N; Shimazaki A; Sakamoto S; Kitade N; Tonomura Y; Ino A; Okuno T
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2498-2503. PubMed ID: 29903660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes.
    Kreuz S; Schoelch C; Thomas L; Rist W; Rippmann JF; Neubauer H
    Diabetes Metab Res Rev; 2009 Sep; 25(6):577-86. PubMed ID: 19618481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotinoyl domain of human acetyl-CoA carboxylase: Structural insights into the carboxyl transfer mechanism.
    Lee CK; Cheong HK; Ryu KS; Lee JI; Lee W; Jeon YH; Cheong C
    Proteins; 2008 Aug; 72(2):613-24. PubMed ID: 18247344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin.
    Kato N; Liang YQ; Ochiai Y; Jesmin S
    Eur J Pharmacol; 2008 Apr; 584(2-3):376-89. PubMed ID: 18295756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of modifications of the linker in a series of phenylpropanoic acid derivatives: Synthesis, evaluation as PPARalpha/gamma dual agonists, and X-ray crystallographic studies.
    Casimiro-Garcia A; Bigge CF; Davis JA; Padalino T; Pulaski J; Ohren JF; McConnell P; Kane CD; Royer LJ; Stevens KA; Auerbach BJ; Collard WT; McGregor C; Fakhoury SA; Schaum RP; Zhou H
    Bioorg Med Chem; 2008 May; 16(9):4883-907. PubMed ID: 18394907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.